BayesPeak: Bayesian analysis of ChIP-seq data

<p>Abstract</p> <p>Background</p> <p>High-throughput sequencing technology has become popular and widely used to study protein and DNA interactions. Chromatin immunoprecipitation, followed by sequencing of the resulting samples, produces large amounts of data that can b...

Full description

Bibliographic Details
Main Authors: Stark Rory, Spyrou Christiana, Lynch Andy G, Tavaré Simon
Format: Article
Language:English
Published: BMC 2009-09-01
Series:BMC Bioinformatics
Online Access:http://www.biomedcentral.com/1471-2105/10/299
_version_ 1818525783574970368
author Stark Rory
Spyrou Christiana
Lynch Andy G
Tavaré Simon
author_facet Stark Rory
Spyrou Christiana
Lynch Andy G
Tavaré Simon
author_sort Stark Rory
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>High-throughput sequencing technology has become popular and widely used to study protein and DNA interactions. Chromatin immunoprecipitation, followed by sequencing of the resulting samples, produces large amounts of data that can be used to map genomic features such as transcription factor binding sites and histone modifications.</p> <p>Methods</p> <p>Our proposed statistical algorithm, BayesPeak, uses a fully Bayesian hidden Markov model to detect enriched locations in the genome. The structure accommodates the natural features of the Solexa/Illumina sequencing data and allows for overdispersion in the abundance of reads in different regions. Moreover, a control sample can be incorporated in the analysis to account for experimental and sequence biases. Markov chain Monte Carlo algorithms are applied to estimate the posterior distributions of the model parameters, and posterior probabilities are used to detect the sites of interest.</p> <p>Conclusion</p> <p>We have presented a flexible approach for identifying peaks from ChIP-seq reads, suitable for use on both transcription factor binding and histone modification data. Our method estimates probabilities of enrichment that can be used in downstream analysis. The method is assessed using experimentally verified data and is shown to provide high-confidence calls with low false positive rates.</p>
first_indexed 2024-12-11T06:13:38Z
format Article
id doaj.art-a16b67fd622344cda05d20623f6df8b5
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-12-11T06:13:38Z
publishDate 2009-09-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-a16b67fd622344cda05d20623f6df8b52022-12-22T01:18:03ZengBMCBMC Bioinformatics1471-21052009-09-0110129910.1186/1471-2105-10-299BayesPeak: Bayesian analysis of ChIP-seq dataStark RorySpyrou ChristianaLynch Andy GTavaré Simon<p>Abstract</p> <p>Background</p> <p>High-throughput sequencing technology has become popular and widely used to study protein and DNA interactions. Chromatin immunoprecipitation, followed by sequencing of the resulting samples, produces large amounts of data that can be used to map genomic features such as transcription factor binding sites and histone modifications.</p> <p>Methods</p> <p>Our proposed statistical algorithm, BayesPeak, uses a fully Bayesian hidden Markov model to detect enriched locations in the genome. The structure accommodates the natural features of the Solexa/Illumina sequencing data and allows for overdispersion in the abundance of reads in different regions. Moreover, a control sample can be incorporated in the analysis to account for experimental and sequence biases. Markov chain Monte Carlo algorithms are applied to estimate the posterior distributions of the model parameters, and posterior probabilities are used to detect the sites of interest.</p> <p>Conclusion</p> <p>We have presented a flexible approach for identifying peaks from ChIP-seq reads, suitable for use on both transcription factor binding and histone modification data. Our method estimates probabilities of enrichment that can be used in downstream analysis. The method is assessed using experimentally verified data and is shown to provide high-confidence calls with low false positive rates.</p>http://www.biomedcentral.com/1471-2105/10/299
spellingShingle Stark Rory
Spyrou Christiana
Lynch Andy G
Tavaré Simon
BayesPeak: Bayesian analysis of ChIP-seq data
BMC Bioinformatics
title BayesPeak: Bayesian analysis of ChIP-seq data
title_full BayesPeak: Bayesian analysis of ChIP-seq data
title_fullStr BayesPeak: Bayesian analysis of ChIP-seq data
title_full_unstemmed BayesPeak: Bayesian analysis of ChIP-seq data
title_short BayesPeak: Bayesian analysis of ChIP-seq data
title_sort bayespeak bayesian analysis of chip seq data
url http://www.biomedcentral.com/1471-2105/10/299
work_keys_str_mv AT starkrory bayespeakbayesiananalysisofchipseqdata
AT spyrouchristiana bayespeakbayesiananalysisofchipseqdata
AT lynchandyg bayespeakbayesiananalysisofchipseqdata
AT tavaresimon bayespeakbayesiananalysisofchipseqdata